Aarti Pharmalabs Limited (AARTIPHARM) reported revenue of ₹536 Cr and net profit of ₹76.14 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
AARTIPHARM fundamentals, Fundamental score 43/100
The statements below are read from Aarti Pharmalabs Limited’s filed results, 13 filed quarters and 6 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 8, 2026 · audited
Sales CAGR · 3Y−2.2%FY22 → FY25
Sales CAGR · 4Y+11.0%FY21 → FY25
PAT CAGR · 3Y−3.3%FY22 → FY25
PAT CAGR · 4Y+9.4%FY21 → FY25
Price · 1Y−2.5%EOD
Price CAGR · 3Y+25.7%EOD
Quarterly resultsConsolidated
₹ Cr
Jun2023
Sep2023
Dec2023
Mar2024
Jun2024
Sep2024
Dec2024
Mar2025
Jun2025
Sep2025
Dec2025
Mar2026
Jun2026Latest
YoYlatest
Sales
458
440
449
506
555
458
538
564
386
418
432
583
536
+38.7%
373
352
353
388
459
364
409
418
291
344
330
470
400
+37.4%
Operating profit
84.9
88.0
95.7
118
96.5
93.7
129
146
95.2
74.7
102
113
136
+42.9%
OPM %
18.5%
20.0%
21.3%
23.2%
17.4%
20.5%
23.9%
25.8%
24.7%
17.9%
23.7%
19.4%
25.4%
+0.7 pp
Other income
0.48
0.98
1.39
2.03
2.22
4.48
5.03
-1.61
1.60
0.05
-0.37
8.05
0.45
-71.6%
Interest
4.17
3.89
4.48
4.68
4.83
5.51
9.97
6.58
6.79
10.7
12.6
16.9
12.9
+89.5%
Depreciation
17.2
18.1
18.8
19.1
20.2
20.9
23.0
22.8
22.8
24.8
28.6
28.2
30.0
+31.7%
Profit before tax
64.0
67.0
73.8
95.8
73.7
71.8
101
115
67.3
39.3
57.9
76.2
93.7
+39.3%
Tax %
26.4%
22.6%
28.5%
31.9%
24.7%
23.9%
26.5%
22.9%
23.7%
27.4%
25.7%
27.0%
26.6%
+2.9 pp
Net profit
47.1
51.8
52.8
65.3
55.5
54.6
74.0
88.3
49.5
27.9
48.0
61.1
76.1
+53.8%
EPS (₹)
5.20
5.72
5.82
7.20
6.12
6.03
8.16
9.75
5.46
3.08
5.29
6.74
8.40
+53.8%
One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split↔ scroll for earlier quarters
Revenue & net profit trend
last 13 quarters
RevenueNet profit
Revenue & net profit — Consolidated13 quarters
Segment results
Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.
Forensic checksauto-scanned from the filing
Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.
How results moved the priceEOD reaction on the session the market could trade the filing
Avg absolute result-day move ±8.1%· EPS surprise: no estimates source· 1 earlier quarter has no dated filing on record
Q1'27filed Fri 7 Aug 19:59 · first tradeable session Mon 10 Auggap +11.2%close +20.0%
Q4'26filed Mon 25 May 21:03 · first tradeable session Tue 26 Maygap −3.5%close −5.2%
Q3'26filed Mon 9 Feb 20:37 · first tradeable session Tue 10 Febgap −5.6%close −3.8%
Q2'26filed Sun 9 Nov 16:27 · first tradeable session Mon 10 Novgap −7.5%close −11.4%
Q1'26filed Tue 12 Aug 19:24 · first tradeable session Wed 13 Auggap −6.6%close −7.7%
Q4'25filed Sat 10 May 19:20 · first tradeable session Mon 12 Maygap +3.8%close +4.4%
Q3'25filed Wed 5 Feb 19:16 · first tradeable session Thu 6 Febgap +15.4%close +6.9%
Q1'25filed Mon 5 Aug 15:46 · first tradeable session Tue 6 Auggap −0.0%close −3.0%
Q4'24filed Mon 13 May 17:27 · first tradeable session Tue 14 Maygap +3.6%close +18.8%
Q3'24filed Wed 7 Feb 16:42 · first tradeable session Thu 8 Febgap +1.6%close −6.9%
Q2'24filed Tue 7 Nov 18:39 · first tradeable session Wed 8 Novgap −3.9%close −6.2%
Q1'24filed Sat 5 Aug 15:52 · first tradeable session Mon 7 Auggap +1.2%close −3.4%
